Paul P. Dobesh, PharmD
Articles
November 17th 2018
Best Practices for Implementing Venous Thromboembolism Prophylaxis Across the Continuum of Care
Paul P. Dobesh, PharmD Tania Ahuja, PharmD George A. Davis, PharmD Hugh Fatodu, MBA, RPh William H. Francis, MBA, RPh Frank P. Hull, MD Gary L. Johnson, MD, MS, MBA Joshua D. Lenchus, DO, BSPharm Jacqueline Glee Lenoir, PharmD Claudette McPherson, RN, BSN Jeffrey Nemeth, PharmD, MPA Ralph J. Riello III, PharmD
November 17th 2018
Paul P. Dobesh, PharmD Tania Ahuja, PharmD George A. Davis, PharmD Hugh Fatodu, MBA, RPh William H. Francis, MBA, RPh Frank P. Hull, MD Gary L. Johnson, MD, MS, MBA Joshua D. Lenchus, DO, BSPharm Jacqueline Glee Lenoir, PharmD Claudette McPherson, RN, BSN Jeffrey Nemeth, PharmD, MPA Ralph J. Riello III, PharmD
November 17th 2018
Paul P. Dobesh, PharmD Tania Ahuja, PharmD George A. Davis, PharmD Hugh Fatodu, MBA, RPh William H. Francis, MBA, RPh Frank P. Hull, MD Gary L. Johnson, MD, MS, MBA Joshua D. Lenchus, DO, BSPharm Jacqueline Glee Lenoir, PharmD Claudette McPherson, RN, BSN Jeffrey Nemeth, PharmD, MPA Ralph J. Riello III, PharmD
March 16th 2012
Adherence and Dosing Frequency of Common Medications for Cardiovascular Patients
Jay P. Bae, PhD Paul P. Dobesh, PharmD Donald G. Klepser, PhD, MBA Johnna D. Anderson, MS Anthony J. Zagar, MS Patrick L. McCollam, PharmD Molly E. Tomlin, MS
In this database analysis, greater adherence was observed for once-daily dosing compared with twice-daily dosing with chronic-use prescription medications used by patients with cardiovascular disease.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: November 21st 2024 | Updated: November 23rd 2024
Polygenic Risk Scores Can Identify Patients Who Should Receive IOP-Lowering Treatment
